These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4671924)

  • 21. Open study with bromperidol (C-C 2489), a new neuroleptic, for the determination of the neuroleptic threshold and the neuroleptic-therapeutic range.
    Haase HJ; Kaumeier S; Schwarz H; Gundel A; Linde OK; Maetz H; Scheel R; Stripf A; Stripf L
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Mar; 11(2):81-5. PubMed ID: 643910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Testing basic visual functions in the evaluation of extrapyramidal side effects of antipsychotic agents].
    Kéri S; Antal A; Szekeres G; Szendi I; Kovács Z; Janka Z; Benedek G
    Orv Hetil; 1998 Feb; 139(5):235-8. PubMed ID: 9489377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extrapyramidal reactions to prochlorperazine and haloperidol in the United Kingdom.
    Bateman DN; Rawlins MD; Simpson JM
    Q J Med; 1986 Jun; 59(230):549-56. PubMed ID: 3749448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical state, plasma levels of haloperidol and prolactin: a correlation study in chronic schizophrenia.
    Rao VA; Bishop M; Coppen A
    Br J Psychiatry; 1980 Dec; 137():518-21. PubMed ID: 7214106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E; Svestka J
    Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticholinergic agents for prophylaxis of neuroleptic-induced dystonic reactions: a prospective study.
    Sramek JJ; Simpson GM; Morrison RL; Heiser JF
    J Clin Psychiatry; 1986 Jun; 47(6):305-9. PubMed ID: 2872206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influencing of biological and immunologic pregnancy reactions by psychotropic drugs].
    Radzuweit H; Knorr W
    Endokrinologie; 1969; 54(1):111-7. PubMed ID: 5358570
    [No Abstract]   [Full Text] [Related]  

  • 28. Reversal of morphine with naloxone precipitates haloperidol-induced extrapyramidal side effects.
    Guo SL; Lin CJ; Huang HH; Chen LK; Sun WZ
    J Pain Symptom Manage; 2006 May; 31(5):391-2. PubMed ID: 16716869
    [No Abstract]   [Full Text] [Related]  

  • 29. [Standard and high doses of haloperidol. Clinical, pharmacokinetic and pharmacodynamic aspects].
    Schilkrut R; Haverbeck C; Duran E; Delgado S; Kohen P; Birkner R; Katz I
    Acta Psiquiatr Psicol Am Lat; 1981; 27(4-5):315-24. PubMed ID: 7348089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot study.
    McEvoy JP; Stiller RL; Farr R
    J Clin Psychopharmacol; 1986 Jun; 6(3):133-8. PubMed ID: 3711363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
    Hebenstreit GF; Laux G; Schubert H; Beckmann H; Amman J; Bunse J; Eikmeier G; Geretsegger C; Kanitz RD; Kanzow WT
    Pharmacopsychiatry; 1991 Sep; 24(5):153-8. PubMed ID: 1685572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haloperidol: fifteen years of clinical experience.
    Ayd FJ
    Dis Nerv Syst; 1972 Jul; 33(7):459-69. PubMed ID: 4675174
    [No Abstract]   [Full Text] [Related]  

  • 33. Protracted vomiting following abrupt cessation of psychotropics: a case report.
    Kalman T; Warner GM
    Can Psychiatr Assoc J; 1978 Apr; 23(3):163-5. PubMed ID: 647615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG; Kopala LC; Rabinowitz J
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptom change and extrapyramidal side effects during acute haloperidol treatment in chronic geriatric schizophrenics.
    Weisbard JJ; Pardo M; Pollack S
    Psychopharmacol Bull; 1997; 33(1):119-22. PubMed ID: 9133762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
    Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
    J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute-onset extrapyramidal syndromes caused by drugs].
    Montoya Cabrera MA; López Martín G; Baca Rodríguez LC; Porcayo Vergara F; Hernández Zamora A; Juárez Aragón G
    Bol Med Hosp Infant Mex; 1981; 38(4):607-15. PubMed ID: 6117295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biochemical mechanisms of extrapyramidal-motoric effect of haloperidol in man].
    Eben E; Ackenheil M; Raese J; Rüther E
    Arzneimittelforschung; 1974 Aug; 24(8):1133-5. PubMed ID: 4479374
    [No Abstract]   [Full Text] [Related]  

  • 39. Combined treatment of schizophrenic psychoses with haloperidol and valproate.
    Dose M; Hellweg R; Yassouridis A; Theison M; Emrich HM
    Pharmacopsychiatry; 1998 Jul; 31(4):122-5. PubMed ID: 9754845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines.
    Menza MA; Murray GB; Holmes VF; Rafuls WA
    Heart Lung; 1988 May; 17(3):238-41. PubMed ID: 2896642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.